Gastrointestinal Disorders

Gastrointestinal motility can be described by the movements of the digestive system, and the transit of the contents within it.Gastrointestinal Disorder is related to gastrointestinal tract namely the esophagus, stomach, small intestine, large intestine, rectum, and the accessory organs of digestion, the liver, gallbladder, and pancreas.Gastrointestinal disorders include such conditions as constipation, hemorrhoids, irritable bowel syndrome, anal fissures, perianal abscesses, anal fistulas, perianal infections, diverticular diseases, colon polyps, colitis and cancer.Many of these can be minimized by maintaining a healthy lifestyle, practicing good bowel habits, and submitting to cancer screening.Less than 1% of digestive disease research funding, through the National Institutes of Health (NIH), is allocated for functional disorders.

• Intestinal Diseases
• Intestinal Obstruction
• Intra gastric Ballon
• Adjustable Gastric band
• Obesity
• Inflamation

Market Statistics:

The global gastrointestinal medicines market is predicted to increase at a CAGR of 4.4% from $46.68 billion in 2020 to $48.74 billion in 2021. The gastrointestinal therapeutics market is anticipated to reach $62.19 billion by 2025, growing at a CAGR of 6%.

The global gastrointestinal medicines industry is fairly fragmented, with only a few major competitors. In 2020, the top 10 competitors in the market accounted for 51.88% of the total market. Takeda Pharmaceuticals, AbbVie, Johnson & Johnson, Bausch Health, and AstraZeneca Plc are among the market's major participants.